FDA signals intent to regulate lab developed tests
DUNEDIN, NZ: Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) notes the U.S. Food and Drug Administration (FDA) has released for public comment proposed rule changes that seek to have Laboratory Developed Tests (LDTs) such as Cxbladder regulated as medical…